The CDC reports a significant increase in ceftriaxone-resistant gonorrhea strains in China from 2017 to 2022, rising from 2.9% to 8.1%. This rate is notably higher than in other nations. Additionally, there is a sharp rise in meningitis serogroup Y cases, with the ST 1466 strain disproportionately affecting adults aged 30 to 60, Black or African American individuals, and those with HIV.
U.S. health officials are warning of an increase in rare bacterial illnesses than can lead to meningitis and possible death https://t.co/nl7DctjAG1
China has a big problem with super gonorrhea, study finds Drug-resistant gonorrhea is a growing problem—one that doesn't heed borders. Health officials have long warned that gonorrhea is becoming more and more resistant to all the antibiotic drugs we have to fight it. Last… https://t.co/lpNyniu9kb
CDC warns of sharp rise in meningitis serogroup Y cases Many involve the ST 1466 strain, which is disproportionately affecting adults ages 30 to 60, Black or African American people, and those with HIV. https://t.co/ZF14FeJa96 Photo: Nathan Reading/Flickr cc https://t.co/HoXFGFNgqf
Super gonorrhea rate quickly triples in China, now 40x higher than US https://t.co/eQo3Y9y1RB
China sees dramatic rise in ceftriaxone-resistant gonorrhea The prevalence of ceftriaxone-resistant Neisseria gonorrhoeae isolates nearly tripled in China from 2017 through 2022. https://t.co/ep6kw5vgwn https://t.co/WQho1sHd4s
Breaking: CDC reports that the prevalence in China of resistance in strains of gonorrhea to ceftriaxone, part of the only recommended regimen against the STI, tripled from 2017-2022, from 2.9% to 8.1%--an "extremely high" rate compared with other nations. https://t.co/vITdQltqk9 https://t.co/cfUq2xg1zE